Results 211 to 220 of about 282,881 (309)
Pedunculoside targets and suppresses CDK4; consequently, it activates the MAPK pathway and inhibits hepatocellular carcinoma progression. ABSTRACT Hepatocellular carcinoma (HCC) remains a major challenge in cancer prevention and treatment, highlighting the urgent need for effective and low‐toxicity anti‐HCC therapies. Recently, CDK4‐targeted inhibitors
Yang Zhou +9 more
wiley +1 more source
Antibodies against hepatitis C virus in hemodialysis patients
Refik MAS +6 more
doaj
Acute Severe Hepatitis B Virus Infection in Previously Vaccinated Patient during Acalabrutinib Treatment. [PDF]
Rojek L +4 more
europepmc +1 more source
[Cryoglobulin and factors associated with it in patient with anti-hepatitis-C antibodies living in resource-limited countries]. [PDF]
Eloumou SAFB +13 more
europepmc +1 more source
Hepatitis C virus and HIV transmission: parenteral (including percutaneous) routes are still relevant and must receive due attention. [PDF]
Vento S, Cainelli F.
europepmc +1 more source
A Pregnant Patient with a Positive Hepatitis C Antibody
Jonathan J Tucci +2 more
openaire +2 more sources
ABSTRACT Scaling up hepatitis C virus (HCV) testing and treatment for people who inject drugs (PWID) is essential to achieve HCV elimination. We report a retrospective systems‐informed qualitative process evaluation of HCV care across multiple community‐based settings in a region in Scotland, UK.
Gabriele Vojt +6 more
wiley +1 more source
Hepatitis E in Thailand: From Seroprevalence to Foodborne and Transfusion-Associated Risks. [PDF]
Poovorawan Y +3 more
europepmc +1 more source
Guidelines for Essential Trauma Care: Second Edition (2026)
Injury is a major cause of death and disability globally, with the highest burden in low‐ and middle‐income countries (LMICs). Strengthening the organization and planning for trauma care (care of the injured) can improve care and lower mortality. In 2004, the International Association for Trauma Surgery and Intensive Care (IATSIC) and the World Health ...
Charles Mock +41 more
wiley +1 more source
Editorial commentary on the special issue of immunology. [PDF]
Board E.
europepmc +1 more source

